Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Raymond Alexander Alfred Smith"'
Autor:
Xiaoman Luo, Chau Sang Lau, Bach Quang Le, Tuan Chun Tan, Jian Hui Too, Raymond Alexander Alfred Smith, Na Yu, Simon M. Cool
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-15 (2023)
Abstract It is challenging to regenerate periodontal tissues fully. We have previously reported a heparan sulfate variant with enhanced affinity for bone morphogenetic protein-2, termed HS3, that enhanced periodontal tissue regeneration in a rodent m
Externí odkaz:
https://doaj.org/article/0cf7a89fd8db47a9b66a4c83dabf92fb
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 8 (2020)
Heparan sulfate proteoglycans (HSPGs) are an evolutionarily ancient subclass of glycoproteins with exquisite structural complexity. They are ubiquitously expressed across tissues and have been found to exert a multitude of effects on cell behavior an
Externí odkaz:
https://doaj.org/article/a331013a36744136a09ba5215857a010
Autor:
Jiayi Guo, Eun Ju Park, Yew Chin Teo, Asyraf Abbas, Denise Goh, Raymond Alexander Alfred Smith, Yuntong Nie, Hang T. L. Nguyen, Joe Poh Sheng Yeong, Simon Cool, Haruyuki Makio, Peili Teo
Publikováno v:
Polymer Chemistry. 14:1743-1751
Bioactive polyethylene incorporating hydrophobic PE-bearing macromonomers and hydrophilic PEGylated-peptide macromonomers was synthesized via ROMP. 3D-printed sheets of it with UHMWPE showed enhanced osteogenic activity for potential orthopaedic appl
Autor:
Yew Chin Teo, Eun Ju Park, Jiayi Guo, Asyraf Abbas, Raymond Alexander Alfred Smith, Denise Goh, Joe Poh Sheng Yeong, Simon Cool, Peili Teo
Publikováno v:
ACS Applied Bio Materials. 5:4770-4778
We report the modular synthesis of bioactive brush-type polycaprolactone-peptide and polylactide-peptide copolymers for applications in bone tissue engineering. The brush copolymers containing pendant side chains of polycaprolactone (PCL) or polylact
Autor:
Akshaya Srinivasan, Padmapriya Sathiyanathan, Lu Yin, Tong Ming Liu, Alan Lam, Maanasa Ravikumar, Raymond Alexander Alfred Smith, Han Ping Loh, Ying Zhang, Ling Ling, Say Kong Ng, Yuan Sheng Yang, Alexander Lezhava, James Hui, Steve Oh, Simon M. Cool
Publikováno v:
Cytotherapy. 24(5)
Therapies using mesenchymal stromal cells (MSCs) to treat immune and inflammatory conditions are now at an exciting stage of development, with many MSC-based products progressing to phase II and III clinical trials. However, a major bottleneck in the